These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4359162)

  • 1. Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
    Parkes JD; Fenton GW
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):1076-81. PubMed ID: 4359162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the treatment of rapid eye movement narcolepsy.
    Guilleminault C; Carskadon M; Dement WC
    Arch Neurol; 1974 Jan; 30(1):90-3. PubMed ID: 4357130
    [No Abstract]   [Full Text] [Related]  

  • 4. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.
    Kanbayashi T; Honda K; Kodama T; Mignot E; Nishino S
    Neuroscience; 2000; 99(4):651-9. PubMed ID: 10974428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.
    Roth B; Faber J; Nevsímalová S; Tosovský J
    Schweiz Arch Neurol Neurochir Psychiatr; 1971; 108(2):251-60. PubMed ID: 4330752
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia.
    Schmidt HS; Clark RW; Hyman PR
    Am J Psychiatry; 1977 Feb; 134(2):183-5. PubMed ID: 189623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
    Kales A; Cadieux RJ; Soldatos CR; Bixler EO; Schweitzer PK; Prey WT; Vela-Bueno A
    Arch Neurol; 1982 Mar; 39(3):164-8. PubMed ID: 7065934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of imipramine, dexphenmetrazine and amphetamine sulfate on synchronous and paradoxical sleep in narcolepsy-cataplexy. A polygraphic study].
    Roth B; Faber J; Nevsímalová S; Tosovský J
    Cesk Neurol; 1970 Jan; 33(1):29-35. PubMed ID: 4312702
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms.
    Arnold LE; Wender PH; McCloskey K; Snyder SH
    Arch Gen Psychiatry; 1972 Dec; 27(6):816-22. PubMed ID: 4564954
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural history, symptoms and treatment of the narcoleptic syndrome.
    Parkes JD; Baraitser M; Marsden CD; Asselman P
    Acta Neurol Scand; 1975 Nov; 52(5):337-53. PubMed ID: 19899267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy.
    Zarcone V
    N Engl J Med; 1973 May; 288(22):1156-66. PubMed ID: 4349356
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings.
    Parkes JD; Fenton G; Struthers G; Curzon G; Kantamaneni BD; Buxton BH; Record C
    Q J Med; 1974 Oct; 43(172):525-36. PubMed ID: 4533510
    [No Abstract]   [Full Text] [Related]  

  • 17. Methysergide in the treatment of narcolepsy.
    Wyler AR; Wilkus RJ; Troupin AS
    Arch Neurol; 1975 Apr; 32(4):265-8. PubMed ID: 164849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder.
    Schenck CH; Mahowald MW
    Ann Neurol; 1992 Jul; 32(1):3-10. PubMed ID: 1642469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical-psychological implications of recent sleep research.
    Pearlman CA; Greenberg R
    Psychiatry Med; 1970 Oct; 1(4):261-76. PubMed ID: 4402296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.